Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome-Reference-Cited by-同舟云学术

Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome

Published:2018-10 Issue:14 Volume:72 Page:1613-1618
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Teixido-Tura Gisela,Forteza Alberto,Rodríguez-Palomares Jose,González Mirelis Jesús,Gutiérrez Laura,Sánchez Violeta,Ibáñez Borja,García-Dorado David,Evangelista Artur

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult;Erbel;Eur Heart J,2014

2. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome;Shores;N Engl J Med,1994

3. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome;Brooke;N Engl J Med,2008

4. Circulating transforming growth factor-beta in Marfan syndrome;Matt;Circulation,2009

5. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome;Neptune;Nat Genet,2003

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases;European Heart Journal;2024-08-30

2. Complement C3a/C3aR inhibition alleviates the formation of aortic aneurysm in Marfan syndrome mice;BMC Cardiovascular Disorders;2024-08-10

3. Arterial aneurysm and dissection: toward the evolving phenotype of Tatton-Brown-Rahman syndrome;Journal of Medical Genetics;2024-07-02

4. Integrated Stress Response Triggered by Excessive Glycosylation Drives Thoracic Aortic aneurysm;2024-06-01

5. A narrative review: cardiovascular aspects of Turner syndrome in the pediatric population;Pediatric Medicine;2024-05